A. H. Robins reiterated plans for the Dalkon Shield.
- Share via
The firm previously stated its intention to establish a reserve for pending and future claims related to the Dalkon Shield, an intrauterine birth-control device formerly marketed by the company. Senior Vice President G. E. R. Stiles, the company’s chief financial officer, stressed that the amount of the reserve, to be charged against income for 1984, has not yet been established.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
